Kenta Mosallanejad

Dr. Kenta Mosallanejad

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2024 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
HHHannah Brown Harding
Hannah Brown Harding
GKGeneva N. Kwaku
Geneva N. Kwaku
CRChristopher M. Reardon
Christopher M. Reardon
NKNida S. Khan
Nida S. Khan
Daniel Zamith-MirandaDaniel Zamith-Miranda
Daniel Zamith-Miranda
Jatin VyasJatin Vyas
Jatin Vyas

13 January 2023 in Science Immunology
Verified
Journal Article
Closed access
KMKenta Mosallanejad
Kenta Mosallanejad
SKStephanie N. Kennedy
Stephanie N. Kennedy
KBKristin M. Bahleda
Kristin M. Bahleda
KSKailey M. Slavik
Kailey M. Slavik
WZWen Zhou
Wen Zhou
JKJonathan C. Kagan
Jonathan C. Kagan
The mechanisms by which innate immune receptors mediate self-nonself discrimination are unclear. In this study, we found species-specific molecular determinants of self-DNA reactivity by cyclic guanosine monophosphate–adenosine monophosphate (GMP–AMP) synthase (cGAS). Human cGAS contained a catalytic domain that was intrinsically self-DNA reactive and stimulated interferon responses in diverse cell types. This reactivity was prevented by an upstream amino (N)-terminal domain. The cGAS proteins from several nonhuman primate species exhibited a similar pattern of self-DNA reactivity in cells, but chimpanzee cGAS was inactive even when its amino-terminal domain was deleted. In contrast, the N terminus of mouse cGAS promoted self-DNA reactivity. When expressed within tumors, only self-DNA–reactive cGAS proteins protected mice from tumor-induced lethality. In vitro studies of DNA- or chromatin-induced cGAS activation did not reveal species-specific activities that correlate with self-DNA reactivity observed in macrophages. Cell biological analysis revealed that self-DNA reactivity by human cGAS, but not mouse cGAS, correlated with localization to mitochondria. We found that epitope tag positions affected self-DNA reactivity in cells and that DNA present in cell lysates undermines the reliability of cGAS biochemical fractionations. These studies reveal species-specific diversity of cGAS functions, even within the primate lineage, and highlight experimental considerations for the study of this innate immune receptor.

4 August 2026 in Cells
Verified
Journal Article
Open access
PDF file
KMKenta Mosallanejad
Kenta Mosallanejad
CHCedric J Hubeau
Cedric J Hubeau
ASAnnette Schwartz Sterman
Annette Schwartz Sterman
YTYunhao Tan
Yunhao Tan
Tissue repair and regeneration are highly coordinated multicellular processes that rely on the active resolution of inflammation rather than merely its passive cessation. Reciprocal orchestration among stromal, innate, and adaptive immune systems is key to maintaining or restoring tissue homeostasis from pathological perturbations. Macrophages serve as a central nexus of these responses, exhibiting dynamic functional plasticity that extends beyond dichotomous M1/M2 classification. This review explores the evolving, context-dependent roles of macrophages in restoring tissue homeostasis, with a particular focus on efferocytosis and subsequent metabolic rewiring as key drivers of inflammation resolution. Furthermore, we highlight the bi-directional crosstalk between macrophages and heterogeneous fibroblast populations. While these stromal-myeloid interactions are essential for transient matrix remodeling and physiological healing, their sustained activation under inflammatory conditions drives maladaptive repair and fibrotic remodeling. We discuss how the defects and dysregulation of these cellular circuits contribute to the pathogenesis of autoimmune disorders, as exemplified by recent findings in rheumatoid arthritis (RA), systemic sclerosis (SSc), and inflammatory bowel disease (IBD). Finally, we evaluate emerging “resolution therapies” that aim to harness endogenous tissue-reparative programs of macrophages therapeutically to treat autoimmune diseases, including the application of specialized pro-resolving mediators (SPMs) and macrophage reprogramming strategies.